Martin Shkreli is an American entrepreneur, investor, and former hedge fund manager. He is best known for his controversial business practices, including raising the price of drugs, as well as his legal issues. He is also the founder of multiple companies, including Turing Pharmaceuticals, KaloBios Pharmaceuticals, and Retrophin. Shkreli has been a subject of much public scrutiny, and has been nicknamed “Pharma Bro” by the media.

Martin Shkreli – Bio

Martin Shkreli was born on April 1, 1983 in Brooklyn, New York. He is the son of Albanian and Croatian immigrants. He attended Hunter College High School before enrolling at Baruch College, where he studied business and finance. In 2009, he founded the hedge fund MSMB Capital Management. He then founded Turing Pharmaceuticals in February 2015, and KaloBios Pharmaceuticals in November 2015.

Shkreli has been involved in several legal disputes. In December 2015, he was arrested on charges of securities fraud. He was also sued by Retrophin, a biopharmaceutical company he founded in 2011, for $65 million. In 2017, Shkreli was found guilty of two counts of securities fraud and one count of conspiracy to commit securities fraud.

Martin Shkreli – Wiki

Martin Shkreli is widely known for his controversial business practices and legal issues. In September 2015, Shkreli raised the price of the drug Daraprim from $13.50 to $750 per pill, a move that was widely criticized. He was also the subject of a Congressional hearing in February 2016, where he refused to answer questions from the House Committee on Oversight and Government Reform.

In addition to his business activities, Shkreli has also been involved in several legal disputes. In December 2015, he was arrested on charges of securities fraud. He was also sued by Retrophin, a biopharmaceutical company he founded in 2011, for $65 million. In 2017, Shkreli was found guilty of two counts of securities fraud and one count of conspiracy to commit securities fraud.

Martin Shkreli – Age & Net Worth

Martin Shkreli is 37 years old. He has a net worth estimated to be around $27 million. He has earned his wealth from his various business ventures, including his hedge fund, Turing Pharmaceuticals, and KaloBios Pharmaceuticals.

Shkreli has also been involved in several legal disputes. In December 2015, he was arrested on charges of securities fraud. He was also sued by Retrophin, a biopharmaceutical company he founded in 2011, for $65 million. In 2017, Shkreli was found guilty of two counts of securities fraud and one count of conspiracy to commit securities fraud.

Martin Shkreli is a controversial figure in the business world. His business practices have been widely criticized, and he has been involved in several legal disputes. Despite the controversy, he has managed to build a successful career and has a net worth estimated to be around $27 million.